BlackRock Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.02M Sell
31,071
-48,143
-61% -$1.44M ﹤0.01% 1849
2016
Q3
$2.5M Sell
79,214
-2,411
-3% -$70.1K ﹤0.01% 1379
2016
Q2
$2.29M Buy
81,625
+16,853
+26% +$661K ﹤0.01% 1381
2016
Q1
$2.35M Buy
64,772
+2,316
+4% +$81.8K ﹤0.01% 1356
2015
Q4
$2.5M Sell
62,456
-14,105
-18% -$492K ﹤0.01% 1325
2015
Q3
$2.18M Buy
76,561
+5,935
+8% +$196K ﹤0.01% 1333
2015
Q2
$2.33M Sell
70,626
-25,647
-27% -$795K ﹤0.01% 1201
2015
Q1
$2.77M Buy
96,273
+1,136
+1% +$32.6K ﹤0.01% 1108
2014
Q4
$2.59M Sell
95,137
-15,550
-14% -$371K ﹤0.01% 1130
2014
Q3
$2.36M Sell
110,687
-7,403
-6% -$170K ﹤0.01% 1132
2014
Q2
$2.65M Buy
118,090
+6,252
+6% +$146K ﹤0.01% 1101
2014
Q1
$2.83M Sell
111,838
-188,152
-63% -$4.75M ﹤0.01% 1093
2013
Q4
$6.9M Buy
299,990
+211,553
+239% +$4.41M 0.01% 916
2013
Q3
$1.69M Buy
88,437
+71,124
+411% +$1.27M ﹤0.01% 1210
2013
Q2
$250K Buy
+17,313
New +$251K ﹤0.01% 2339

Other funds holding EBS

BlackRock Advisors's EBS Position: Q4 2016 in Review

BlackRock Advisors reduced its Emergent Biosolutions (EBS) stake by 61% in Q4 2016, selling an estimated $1.44M and leaving 31,071 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

BlackRock Advisors first reported a position in EBS in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.9M in Q4 2013. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • BlackRock Advisors held 31,071 shares of Emergent Biosolutions worth $1.02M as of Q4 2016.
  • BlackRock Advisors sold 48,143 Emergent Biosolutions shares in Q4 2016, an estimated $1.44M.
  • Emergent Biosolutions made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1849 holding.
  • BlackRock Advisors first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Emergent Biosolutions position peaked at $6.9M in Q4 2013.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.